Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

Similar articles for PubMed (Select 18252883)

1.

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.

Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS.

JAMA. 2008 Feb 6;299(5):532-9. doi: 10.1001/jama.299.5.532. Erratum in: JAMA. 2008 May 28;299(20):2390.

PMID:
18252883
2.

Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system.

Ho PM, Tsai TT, Wang TY, Shetterly SM, Clarke CL, Go AS, Sedrakyan A, Rumsfeld JS, Peterson ED, Magid DJ.

Circ Cardiovasc Qual Outcomes. 2010 May;3(3):303-8. doi: 10.1161/CIRCOUTCOMES.109.890707. Epub 2010 Mar 30.

3.

Discontinuation of long-term clopidogrel therapy is associated with death and myocardial infarction after saphenous vein graft percutaneous coronary intervention.

Sachdeva A, Bavisetty S, Beckham G, Shen AY, Aharonian V, Mansukhani P, Stone GW, Leon M, Moses J, Moore N, Hyett R, Contreras R, Brar SS.

J Am Coll Cardiol. 2012 Dec 11;60(23):2357-63. doi: 10.1016/j.jacc.2012.09.014. Epub 2012 Nov 7.

4.

The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.

Rogowski W, Burch J, Palmer S, Craigs C, Golder S, Woolacott N.

Health Technol Assess. 2009 Jun;13(31):iii-iv, ix-xi, 1-77. doi: 10.3310/hta13310. Review.

5.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS.

JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.

PMID:
19258584
6.

High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

Parodi G, Marcucci R, Valenti R, Gori AM, Migliorini A, Giusti B, Buonamici P, Gensini GF, Abbate R, Antoniucci D.

JAMA. 2011 Sep 21;306(11):1215-23. doi: 10.1001/jama.2011.1332.

PMID:
21934054
7.

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US.

Stephenson JJ, Chang CL, Devecchis Wygant G, Hauch O, Cziraky MJ.

Curr Med Res Opin. 2011 Jun;27(6):1079-87. doi: 10.1185/03007995.2011.568060. Epub 2011 Mar 28.

PMID:
21438795
8.

Prognosis of patients suffering an acute coronary syndrome while already under chronic clopidogrel therapy.

Bonello L, De Labriolle A, Lemesle G, Steinberg DH, Roy P, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.

Catheter Cardiovasc Interv. 2009 Jun 1;73(7):866-70. doi: 10.1002/ccd.21935.

PMID:
19198009
9.

Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.

Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Rabbani LE, Parise H, Stone GW; HORIZONS-AMI Trial Investigators.

J Am Coll Cardiol. 2009 Oct 6;54(15):1438-46. doi: 10.1016/j.jacc.2009.06.021.

10.

Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.

Aradi D, Tornyos A, Pintér T, Vorobcsuk A, Kónyi A, Faluközy J, Veress G, Magyari B, Horváth IG, Komócsi A.

J Am Coll Cardiol. 2014 Mar 25;63(11):1061-70. doi: 10.1016/j.jacc.2013.12.023. Epub 2014 Jan 30.

11.

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, Lewis BS, Murphy SA, McCabe CH, Braunwald E; Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators.

JAMA. 2005 Sep 14;294(10):1224-32. Epub 2005 Sep 4.

PMID:
16143698
12.

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ; CREDO Investigators. Clopidogrel for the Reduction of Events During Observation.

JAMA. 2002 Nov 20;288(19):2411-20. Erratum in: JAMA. 2003 Feb 26;289(8):987..

PMID:
12435254
13.

Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.

Feldman DN, Fakorede F, Minutello RM, Bergman G, Moussa I, Wong SC.

Am J Cardiol. 2010 Feb 1;105(3):323-32. doi: 10.1016/j.amjcard.2009.09.034. Epub 2009 Dec 22.

PMID:
20102943
14.

Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).

Patti G, Pasceri V, Mangiacapra F, Colonna G, Vizzi V, Ricottini E, Montinaro A, D'Ambrosio A, Wijns W, Barbato E, Di Sciascio G; ARMYDA-8 RELOAD-ACS Investigators.

Am J Cardiol. 2013 Jul 15;112(2):162-8. doi: 10.1016/j.amjcard.2013.03.008. Epub 2013 Apr 18.

PMID:
23601577
15.

Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).

Kunadian V, James SK, Wojdyla DM, Zorkun C, Wu J, Storey RF, Steg PG, Katus H, Emanuelsson H, Horrow J, Maya J, Wallentin L, Harrington RA, Gibson CM.

JACC Cardiovasc Interv. 2013 Jul;6(7):671-83. doi: 10.1016/j.jcin.2013.03.014.

16.

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study.

Charlot M, Nielsen LH, Lindhardsen J, Ahlehoff O, Olsen AM, Hansen ML, Hansen PR, Madsen JK, Køber L, Gislason GH, Torp-Pedersen C.

Eur Heart J. 2012 Oct;33(20):2527-34. doi: 10.1093/eurheartj/ehs202. Epub 2012 Jul 12.

17.

Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.

Wiederkehr D, Berenson K, Casciano R, Stern L, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J.

Curr Med Res Opin. 2009 Sep;25(9):2317-25. doi: 10.1185/03007990903156061.

PMID:
19635042
18.

Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.

Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q.

Pharmacotherapy. 2012 Sep;32(9):809-18. doi: 10.1002/j.1875-9114.2012.01112.x. Epub 2012 Jun 28.

19.

Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA, Gersh BJ, Ohman EM, White HD, Moses JW, Ware JH, Lincoff AM, Stone GW.

J Am Coll Cardiol. 2009 May 26;53(21):1965-72. doi: 10.1016/j.jacc.2009.03.006.

20.

Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.

Bonde L, Sorensen R, Fosbøl EL, Abildstrøm SZ, Hansen PR, Kober L, Schramm TK, Bretler DM, Weeke P, Olesen J, Torp-Pedersen C, Gislason GH.

J Am Coll Cardiol. 2010 Mar 30;55(13):1300-7. doi: 10.1016/j.jacc.2009.11.057.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk